Anacetrapib
Cat.No:IA2180 Solarbio
CAS:875446-37-0
Molecular Formula:C30H25F10NO3
Molecular Weight:637.51
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > AnacetrapibCAS:875446-37-0
Molecular Formula:C30H25F10NO3
Molecular Weight:637.51
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 875446-37-0 |
| Name | Anacetrapib |
| Molecular Formula | C30H25F10NO3 |
| Molecular Weight | 637.51 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 1312995-182-4 |
| MDL | MFCD16294903 |
| SMILES | O=C1O[C@@H]([C@@H](N1CC2=CC(C(F)(F)F)=CC=C2C3=CC(C(C)C)=C(C=C3OC)F)C)C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4 |
| InChIKey | MZZLGJHLQGUVPN-HAWMADMCSA-N |
| InChI | InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1 |
| PubChem CID | 11556427 |
| Target Point | CETP |
| Passage | Metabolic Enzyme&Protease |
| Background | Anacetrapib is a potent CETP inhibitor. |
| Biological Activity | Anacetrapib 是一种有效的 CETP 抑制剂,作用于 rhCETP 和 C13S CETP 突变型,IC50 分别为 7.9±2.5 nM 和 11.8±1.9 nM[1]。 |
| IC50 | 7.9±2.5nM(rhCETP),11.8±1.9nM(CETPC13S)[1] |
| Data Literature Source | [1]. Niesor EJ,et al. Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport. J Lipid Res. 2010,51(12),3443-3454. [2]. Dong B,et al. CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism. Atherosclerosis. 2014 Aug;235(2):449-62. [3]. Tan EY,et al. Pharmacokinetics,metabolism,and excretion of anacetrapib,a novel inhibitor of the cholesteryl ester transfer protein,in rats and rhesus monkeys. Drug Metab Dispos. 2010,38(3),459-473. |
| Unit | Bottle |
| Specification | 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download